Search

Penumbra Inc

Fechado

SetorSaúde

324.02 0.56

Visão Geral

Variação de preço das ações

24h

Atual

Mín

321.02

Máximo

323.64

Indicadores-chave

By Trading Economics

Rendimento

163M

33M

Vendas

-11M

375M

P/E

Médio do Setor

73.446

64.641

EPS

1.01

Margem de lucro

8.695

Funcionários

4,700

EBITDA

-22M

47M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.59% upside

Dividendos

By Acuity

Próximos Ganhos

4 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-203M

13B

Abertura anterior

323.46

Fecho anterior

324.02

Sentimento de Notícias

By Acuity

100%

0%

320 / 340 Ranking em Healthcare

Penumbra Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24 de jul. de 2026, 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Comparação entre Pares

Variação de preço

Penumbra Inc Previsão

Preço-alvo

By TipRanks

11.59% parte superior

Previsão para 12 meses

Média 358.4 USD  11.59%

Máximo 374 USD

Mínimo 320 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Penumbra Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

1

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

320 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat